Clinical Trial Update: Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients with Prostate Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the impact of 18F-PSMA PET/CT in managing prostate cancer has completed, assessing how this imaging strategy informs patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-PSMA PET/CT tracer (18F-PSMA)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: 18F-PSMA, Prostate Cancer | Phase 2 | Status: COMPLETED